Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.4B | 7.3B | 6.8B | 9.3B |
Cost of revenue | 6.6B | 5.6B | 5.3B | 6.8B |
Gross profit | 2.8B | 1.8B | 1.6B | 2.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 505.1M | 699.5M | 450.3M | 440.6M |
Operating income | 1.5B | 292.8M | 334.5M | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 1.2B | 1.2B | 1.2B | 1.2B |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 43.3M | -13.5M | 930M |
Tax provision | 0 | 0 | 0 | 0 |
Net income | 1.3B | 43.3M | -13.5M | 930M |
Basic EPS | — | 0.0 | 0.0 | 0.2 |
Diluted EPS | — | 0.0 | 0.0 | 0.2 |
Basic average shares | — | 4.3B | 5.4B | 5.5B |
Diluted average shares | — | 4.3B | 5.4B | 5.5B |
EBITDA | 3.0B | 1.8B | 1.8B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |